Journal of Diabetes Investigation: Vol. 12, Issue 9 Review
This month's issue highlights powerful clinical breakthroughs and practical insights across the spectrum of diabetes care. Key themes include how digital health and remote monitoring dashboards can drastically improve hospital stay durations, the direct nerve-healing benefits of intensive blood sugar control, and how lifestyle containment measures during the pandemic affected younger and older populations in different ways.
Additionally, researchers explore critical safety warnings regarding SGLT2 inhibitor use in Type 1 diabetes, the profound value of immediate nutritional and eye exams in preventing treatment dropouts, and the underlying commonalities between Type 1 and Type 2 diabetes cell failures.
This article was created with the assistance of AI. Although the content is based on original research articles and other academic sources, errors may be present. Please verify the information using the original articles and consult qualified healthcare professionals for medical advice.
Electronic Dashboard-Based Remote Glycemic Management Program Reduces Length of Stay and Readmission Rate Among Hospitalized Adults
Authors: Yi‐Jing Sheen, Chien‐Chung Huang, Shih‐Che Huang, Ching‐Heng Lin, I‐Te Lee, Wayne H‐H Sheu
Research Objective: To evaluate the clinical impact of a 4-year, hospital-wide remote blood glucose monitoring dashboard on the length of hospital stay (LOS) and 30-day readmission rates for hospitalized adult patients.
Methods: A retrospective study evaluating 106,528 hospitalized patients who received glucose monitoring. Patients were divided into four glycemic categories ranging from high variability, hypoglycemia, hyperglycemia, to relatively stable control. Researchers tracked change trends using joinpoint regression from 2016 to 2019.
Main Findings: Implementing the dashboard led to a significant shift from poor blood sugar control categories to the stable group. There was an 11.4% reduction in length of hospital stay and a drop in 30-day readmissions (from 29.9% to 29.3%), primarily driven by patients achieving stable control.
Clinical Significance: Utilizing structured digital remote management tools across an entire hospital system optimizes patient recovery times, reduces the risk of readmission, and decreases associated medical costs.
Key Points for Patients: When hospitals use advanced digital dashboards to closely monitor and manage blood sugar levels remotely, patients recover faster, spend less time in hospital beds, and are less likely to be readmitted shortly after discharge.
Lifestyle Changes as a Result of COVID-19 Containment Measures: Bodyweight and Glycemic Control in Patients with Diabetes in the Japanese Declaration of a State of Emergency
Authors: Nagaaki Tanaka, Yoshiyuki Hamamoto, Yuri Kurotobi, Yuji Yamasaki, Susumu Nakatani, Miho Matsubara, Takuya Haraguchi, Yuko Yamaguchi, Kiyohiro Izumi, Yuki Fujita, Hitoshi Kuwata, Takanori Hyo, Yuichiro Yamada, Takeshi Kurose, Yutaka Seino
Research Objective: To clarify how lifestyle changes during the Japanese COVID-19 state of emergency affected metabolic status, body weight, and HbA1c levels in patients with diabetes.
Methods: A single-center, cross-sectional observational study using a self-reported questionnaire from 463 patients to record active habits before and after containment measures. The analysis was stratified by age (under 65 versus 65 and older).
Main Findings: Shifts in HbA1c levels directly correlated with body weight changes. For patients under 65, increased snacking significantly elevated body weight and HbA1c. Conversely, for patients aged 65 and older, weight gain was primarily associated with reduced walking activity.
Clinical Significance: Public health containment measures impact diabetes management in age-dependent ways, requiring customized guidance (snacking management for younger adults and mobility-maintenance programs for seniors).
Key Points for Patients: Major disruptions to daily routines, like pandemic lockdowns, affect our health differently depending on our age. Younger individuals may need to watch mid-day snacking, whereas older adults should focus on maintaining daily physical activities like walking.
β-Cell Failure in Diabetes: Common Susceptibility and Mechanisms Shared Between Type 1 and Type 2 Diabetes
Authors: Hiroshi Ikegami, Naru Babaya, Shinsuke Noso
Research Objective: To review shared genetic susceptibilities and common biological pathways of pancreatic beta-cell (insulin-producing cell) failure across both Type 1 and Type 2 diabetes subtypes.
Methods: A comprehensive review of recent literature examining molecular mechanisms and genetic markers involved in diabetic beta-cell degradation.
Main Findings: Despite having distinct starting causes and immune system profiles, Type 1 and Type 2 diabetes share key downstream genetic susceptibilities and molecular pathways that lead to cellular stress and eventual beta-cell death.
Clinical Significance: Pinpointing these universal destructive mechanisms helps researchers design overarching therapies capable of preserving insulin secretion regardless of the patient's specific diabetes subtype.
Key Points for Patients: Although Type 1 and Type 2 diabetes are different conditions, they share a "common enemy" in how their insulin-producing cells fail. Scientists are using these shared biological pathways to research new treatments that could help individuals with either type of diabetes.
Glucokinase is Required for High-Starch Diet-Induced β-Cell Mass Expansion in Mice
Authors: Kazuhisa Tsuchida, Akinobu Nakamura, Hideaki Miyoshi, Kelaier Yang, Yuki Yamauchi, Shinichiro Kawata, Kazuno Omori, Kiyohiko Takahashi, Naoyuki Kitao, Hiroshi Nomoto, Hiraku Kameda, Kyu Yong Cho, Yusuke Seino, Yasuo Terauchi, Tatsuya Atsumi
Research Objective: To determine if glucokinase—a key enzyme in glucose metabolism—is necessary for the pancreas to expand its beta-cell mass when exposed to a high-starch diet (HSTD).
Methods: Eight-week-old male wild-type and glucokinase-heterozygous (Gck+/-) mice were fed either a high-starch diet or a control diet, followed by physical and microscopic evaluations of pancreatic tissues.
Main Findings: A high-starch diet naturally triggers an expansion of beta-cell mass and increased insulin secretion in normal wild-type mice, but this crucial protective adaptation is disrupted or impaired in mice lacking a fully functional glucokinase enzyme.
Clinical Significance: This study highlights the essential role of glucokinase in helping the pancreas adapt to carbohydrate-heavy diets, further elucidating how dietary elements interact with genetics.
Key Points for Patients: Laboratory studies show that our bodies rely on specific enzymes (like glucokinase) to help the pancreas safely handle and adapt to high-carbohydrate or high-starch foods. If these enzymes do not function properly, the body may struggle to produce the extra insulin it needs.
On-Label Use of Sodium-Glucose Cotransporter 2 Inhibitors Might Increase the Risk of Diabetic Ketoacidosis in Patients with Type 1 Diabetes
Authors: Takeshi Horii, Yoichi Oikawa, Koichiro Atsuda, Akira Shimada
Research Objective: To investigate the real-world risk and timeline of diabetic ketoacidosis (DKA) in patients with Type 1 diabetes who are treated with SGLT2 inhibitors alongside insulin.
Methods: A retrospective, observational cohort study using a major Japanese clinical database. Out of 11,475 adult Type 1 diabetes patients, 1,898 were taking prescribed SGLT2 inhibitors. Incidence rates and hazard ratios of DKA were calculated using Cox multivariate regression.
Main Findings: Patients taking SGLT2 inhibitors experienced a significantly higher rate of DKA compared to non-users (7.3% vs. non-users; Hazard Ratio: 1.66). The average time to DKA onset was approximately 30.6 days after starting the drug, regardless of age, sex, or BMI. Interestingly, patients using continuous subcutaneous insulin pumps did not show an elevated risk, though the sample size was small.
Clinical Significance: Clinicians and Type 1 diabetes patients must be highly vigilant regarding DKA risks when initiating SGLT2 inhibitors, particularly during the critical first month of therapy.
Key Points for Patients: While SGLT2 inhibitors can offer benefits, if you have Type 1 diabetes, starting this medication carries an increased risk of a severe, life-threatening condition called diabetic ketoacidosis (DKA). This risk is highest during the first 30 days, making close monitoring and direct contact with your care team essential.
Painful Diabetic Neuropathy is Associated with Increased Nerve Regeneration in Patients with Type 2 Diabetes Undergoing Intensive Glycemic Control
Authors: Georgios Ponirakis, Muhammad A Abdul‐Ghani, Amin Jayyousi, Mahmoud A Zirie, Murtaza Qazi, Hamad Almuhannadi, Ioannis N Petropoulos, Adnan Khan, Hoda Gad, Osama Migahid, Ayman Megahed, Salma Al‐Mohannadi, Fatema AlMarri, Fatima Al‐Khayat, Ziyad Mahfoud, Hanadi Al Hamad, Marwan Ramadan, Ralph DeFronzo, Rayaz A Malik
Research Objective: To discover if the presence of painful diabetic nerve damage (neuropathy) impacts the physical regeneration of microscopic corneal (eye) nerves in Type 2 diabetes patients undergoing intensive blood sugar control.
Methods: An exploratory 1-year study evaluating participants with and without painful neuropathy using corneal confocal microscopy (to map small nerve fibers in the eye), skin conductance tests, and pain questionnaires. Patients received active therapies (exenatide + pioglitazone or intensive basal-bolus insulin).
Main Findings: Following intensive glycemic control and a significant drop in HbA1c, patients suffering from painful neuropathy showed a remarkable physical increase in corneal nerve fiber density, nerve length, and branching, alongside a notable decrease in their physical pain scores.
Clinical Significance: Active, rigorous blood sugar management doesn't just halt neuropathy; it actively facilitates small nerve fiber repair and yields real-world pain relief for patients.
Key Points for Patients: Committing to strict blood sugar control can actually help your body rebuild damaged small nerves. Over a year, this structural healing was shown to significantly reduce the daily, distressing pain caused by neuropathy.
Association Between Nutritional Guidance or Ophthalmological Examination and Discontinuation of Physician Visits in Patients with Newly Diagnosed Diabetes: A Retrospective Cohort Study Using a Nationwide Database
Authors: Akira Okada, Sachiko Ono, Satoko Yamaguchi, Hayato Yamana, Kayo Ikeda Kurakawa, Nobuaki Michihata, Hiroki Matsui, Masaomi Nangaku, Toshimasa Yamauchi, Hideo Yasunaga, Takashi Kadowaki
Research Objective: To investigate if completing guideline-recommended care (such as nutritional counseling or professional eye exams) within the first month of a diabetes diagnosis prevents patients from dropping out of medical follow-ups.
Methods: A retrospective cohort study analyzing 6,508 newly diagnosed diabetes patients from a nationwide Japanese administrative database. Discontinuation of care was defined as going more than 6 months without a clinical visit.
Main Findings: Patients who underwent nutritional counseling or eye exams within their first month had a significantly lower medical dropout rate (17.2%) compared to those who did not receive these services (21.8%), demonstrating a 21% relative reduction in care abandonment.
Clinical Significance: Early engagement through multi-disciplinary care (nutritional support and preventative screening) is a powerful clinical strategy to keep new patients actively enrolled in long-term diabetes management.
Key Points for Patients: Getting a nutritional consultation or an eye exam right after being diagnosed with diabetes does more than protect your eyesight and diet; it helps you build a strong connection with your healthcare team and keeps you from falling out of the medical system.
Association Between Serum Prostate-Specific Antigen Concentrations and the Risk of Developing Type 2 Diabetes Mellitus in Chinese Men: A Cohort Study
Authors: Shao‐fen Huang, Ying‐lin Yu, Yun‐feng Cui, Yan‐mei Lou, Min‐qi Liao, Chang‐yi Wang, Shan Xu, Hong‐en Chen, Xu‐ping Gao, Shu‐hong Dai, Xiao‐lin Peng, Dan Zhao, Li Wang, Zhao Ping, Fang‐fang Zeng
Research Objective: To explore the long-term relationship between blood levels of prostate-specific antigen (PSA) and the risk of developing Type 2 diabetes in men.
Methods: A cohort study following 16,811 non-diabetic Chinese men receiving annual health checkups over a median period of 3.8 years. Multi-variable analyses adjusted for age, weight, and other health variables.
Main Findings: Men with higher baseline levels of PSA in their blood had a significantly lower risk of developing Type 2 diabetes. This protective association was particularly prominent among men who were overweight or obese.
Clinical Significance: PSA levels could potentially serve as a biological marker to help doctors gauge and identify Type 2 diabetes risk in male patients.
Key Points for Patients: In men, especially those who struggle with weight, having a slightly higher (but normal) PSA level was associated with a lower chance of developing Type 2 diabetes. Future studies are working to understand the exact biological link behind this trend.
Insulin Resistance is Independently Associated with Cardiovascular Autonomic Neuropathy in Type 2 Diabetes
Authors: Yingshan Liu, Yu Peng, Jing Jin, Yanshan Chen, Chuna Chen, Zhenguo Chen, Haishan Huang, Lingling Xu
Research Objective: To investigate the relationship between insulin resistance severity (measured by HOMA2-IR based on C-peptide) and the development of diabetic cardiovascular autonomic neuropathy (DCAN), a dangerous form of nerve damage affecting the heart.
Methods: A clinical study of 109 patients with Type 2 diabetes. DCAN was diagnosed using Ewing tests (cardiovascular reflex tests). The HOMA2-IR index was used to precisely quantify insulin resistance.
Main Findings: Insulin resistance was significantly higher in patients with cardiovascular nerve damage and worsened as the damage progressed. Patients with a HOMA2-IR score greater than 1.735 were at a very high risk of DCAN, and this score proved to be a highly accurate diagnostic predictor.
Clinical Significance: Severe insulin resistance is a strong independent predictor of cardiac nerve damage, highlighting HOMA2-IR as a valuable, simple screening tool to identify high-risk patients before severe heart complications occur.
Key Points for Patients: When the body's cells resist insulin too strongly, it doesn't just raise blood sugar; it also places the nerves that control your heart rate and blood pressure at risk. A simple blood test calculation can tell your doctor if you are in the high-risk zone, allowing for early, protective treatments.
